US Stock MarketDetailed Quotes

XERS Xeris Pharmaceuticals

Watchlist

1.750
+0.050+2.94%

Close Apr 26 16:00 ET

1.750
0.0000.00%

Post 17:40 ET

259.44MMarket Cap-3888P/E (TTM)

Xeris Pharmaceuticals Stock Forum

Moomoo AI

Mar 2 22:00

Despite Xeris Biopharma Holdings' strong performance, its growth projections are subdued compared to the industry. This could lead to a share price decline if the P/S ratio falls to align with the growth outlook.

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shares Climb 29% But Its Business Is Yet to Catch Up

SpyderCall

Jan 10 21:56

Making Moves in Premarket.

$Xeris Pharmaceuticals(XERS.US)$

Sturgeons and Stocks

Jan 10 21:42

$Xeris Pharmaceuticals(XERS.US)$

Trytosaveabit

Jan 10 21:05

News

$Xeris Pharmaceuticals(XERS.US)$Moomoo 24/7· 1 min ago1min
Xeris Biopharma Enters Into An Exclusive Worldwide License Agreement With Amgen For Xeriject Formulation Of Teprotumumab For Thyroid Eye Disease; Xeris Has The Potential To Receive $75M In Development And Regulatory Milestones

Moomoo AI

Jan 6 03:44

Xeris Biopharma's poor revenue growth forecast and subpar industry growth dampen optimism around the stock’s future. Despite a share price surge, market sentiment remains pessimistic and strong future increases appear unlikely.

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shares Bounce 32% But Its Business Still Trails The Industry

Trytosaveabit

Oct 17, 2023 00:47

$Xeris Pharmaceuticals(XERS.US)$ I guess tweaks to company can help? hehehe! Company Tightened FY23 Revenue Guidance and Raised 2023 Cash, Cash Equivalents and Short-term Investment Guidance